ArticleIranian journal of public health2022
Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer.
Article in Iranian journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Survival Rate of Breast Cancer and Related Factors in Iran: A 27-Year Follow-Up.Iranian journal of public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The study aimed to estimate the overall and disease-free survival rates of breast cancer patients and the factors affecting these rates. Methods: In this retrospective study, data were obtained from 686 patients diagnosed with breast cancer in Sivas Cumhuriyet University Faculty of Medicine Research and Application Hospital Oncology Center between 1988 and 2014. Total population sampling method was used. The survival rates at certain periods were determined by creating a Life Table. By using the Kaplan-Meier Analysis, the mean survival times and rates were determined, and whether the variables had an impact on survival was examined. By applying Cox regression analysis, the effect of prognostic factors that are significant on the survival time of breast cancer patients was examined. Results: Overall mean survival time was found as 208.4±11.8 months. According to Kaplan-Meier analysis, 1, 5, 10 and 20-years overall survival rates were 96.6 ± 0.07%, 82.3 ± 1.7%, 64.4 ± 3.4% and 49%± 7.4%, respectively. According to Cox regression analysis results, variables that influence overall survival time were found as disease stage, multicentricity status, ECOG (performance status), presence of diabetes, CA15-3 value, neutro-phil/lymphocyte ratio. Moreover, variables that had an impact on the disease-free survival time were found as tumor grade, multicentricity, and ECOG. Conclusion: Many factors other than disease can prolong survival or accelerate death. Considering the findings of this study may be useful in planning the treatment of breast cancer patients have positive affect on overall survival rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.